Advertisement
News
Advertisement

Acton Pharma ready to launch asthma treatment

Thu, 09/20/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Acton Pharmaceuticals Inc. of Marlborough his received approval from the U.S. Food and Drug Administration of its supplemental New Drug Appliciation (sNDA) for an inhaled steroid to treat asthma.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading